3E Bioventures (China) Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
5
- Investments
-
118
- Portfolio
-
66
- Exits
-
26
3E Bioventures (China) General Information
Company Description
Founded in 2015, 3E Bioventures is a venture capital firm based in Beijing, China. The firm prefers to invest in companies operating in healthcare devices and supplies, healthcare services, and drug discovery sectors.
Business Details
Website
3ebiovc.cnYear Founded
Investor Status
Primary Investor Type
Corporate Office
- Room 1201, Building D, Tsinghua Science Park Science Building
- Number 1 Zhongguancun East Road, Haidian District
- Beijing, 100084
- China
3E Bioventures (China) Investments (118)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Matwings Technology | 13-Jul-2026 | Early Stage VC | Discovery Tools (Healthcare) | Generating Revenue | ||
| JHM Biopharma | 08-Jun-2026 | Drug Delivery | Generating Revenue | |||
| Yimou Biotechnology | 08-May-2026 | Drug Discovery | Generating Revenue | |||
| Matwings Technology | 06-Feb-2026 | Discovery Tools (Healthcare) | Generating Revenue | |||
| Hopson Technology | 31-Dec-2025 | Biotechnology | Generating Revenue | |||
| OncoC4 | 30-Sep-2025 | Drug Discovery | Clinical Trials - Phase 3 | |||
| Rapafusyn Pharmaceuticals | 04-Sep-2025 | Drug Discovery | Pre-Clinical Trials | |||
| UltraClear | 21-Apr-2025 | Other Healthcare Technology Systems | Generating Revenue | |||
| CellBri | 07-Jan-2025 | Later Stage VC | Diagnostic Equipment | Generating Revenue | ||
| Matwings Technology | 14-Nov-2024 | Early Stage VC | Discovery Tools (Healthcare) | Generating Revenue |
3E Bioventures (China) Exits (26)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| 23Mofang | 16-Sep-2026 | Secondary Transaction - Private | |
| Alebund Pharmaceuticals | 29-Jun-2026 | ||
| Cullgen | 04-May-2026 | ||
| Quadriga BioSciences | 01-Mar-2026 | ||
| Profusa | 11-Jul-2025 | ||
| Sinotau | 19-Dec-2024 | ||
| AcroImmune | 25-Sep-2024 | ||
| Sinotau | 07-Jul-2023 | ||
| OPM Biosciences | 02-Sep-2022 | IPO | |
| Biocytogen Pharmaceuticals (Beijing) Co | 01-Sep-2022 | IPO |
3E Bioventures (China) Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
3E Bioventures (China) Co-Investors (121)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Proxima Capital | 3 |
|
|
||
| Shanghai Hongsheng Junhao Equity Investment Fund Management |
|
|
|||
| Yijing Capital |
|
|
|||
| Co-Stone Capital |
|
|
|||
| LAV (Lilly Asia Fund) |
|
|
3E Bioventures (China) FAQs
-
What is 3E Bioventures (China)?
Founded in 2015, 3E Bioventures is a venture capital firm based in Beijing, China.
-
When was 3E Bioventures (China) founded?
3E Bioventures (China) was founded in 2015.
-
Where is 3E Bioventures (China) headquartered?
3E Bioventures (China) is headquartered in Beijing, China.
-
How many investments has 3E Bioventures (China) made?
3E Bioventures (China) has made 118 investments.
-
What has 3E Bioventures (China) invested in?
3E Bioventures (China) has made numerous investments in companies like Matwings Technology, JHM Biopharma, and Yimou Biotechnology within the Discovery Tools (Healthcare), Drug Delivery, and Drug Discovery industries.
-
What has 3E Bioventures (China) invested in recently?
3E Bioventures (China)'s latest investment was on 13-Jul-2026 in Matwings Technology, a company within the Discovery Tools (Healthcare) industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
